Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UQCRHP2 is a pseudogene in the human genome related to the ubiquinol-cytochrome c reductase hinge protein (UQCRH), which is a nuclear-encoded component of the mitochondrial respiratory chain complex III. However, as a pseudogene, UQCRHP2 does not produce a functional protein and is not recognized as a therapeutic target, nor is it known to participate in any biological pathway, disease process, or drug interaction. Pseudogenes may occasionally have regulatory RNA functions, but current published results do not attribute any characterized biological or clinical role to UQCRHP2. Therefore, UQCRHP2 is not considered a receptor, enzyme, transporter, or molecular target in drug discovery or biomedical research.\n\nIf your intention was to identify a protein or target related to the mitochondrial electron transport chain, the functional protein is "ubiquinol-cytochrome c reductase hinge protein" (UQCRH)[1], not UQCRHP2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquinol-cytochrome c reductase hinge protein pseudogene 2 (UQCRHP2).